Shopping Cart 0
Cart Subtotal
AED 0

Benign Prostatic Hyperplasia (BPH) Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 8368

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 9102

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 10460

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 10460

Details

According to 99Strategy, the Global Benign Prostatic Hyperplasia (BPH) Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Benign Prostatic Hyperplasia (BPH) Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Astellas Pharma

Eli Lilly

GlaxoSmithKline

Sanofi

ADC Therapeutics

Bayer HealthCare

Bristol-Myers Squibb

Valeant Pharmaceuticals

Endo Pharmaceuticals

Foresee Pharmaceuticals

Madrigal Pharmaceuticals

Merck

Novartis

Spectrum Pharmaceuticals

Takeda Pharmaceuticals

Teva

Advaxis

ANI Pharmaceuticals

BHR Pharma

Key Product Type

Alpha-blocker

Phosphodiesterase Type-5 Inhibitors

5-alpha-Reductase Inhibitors

Market by Application

Hospitals

Clinics

Others

Main Aspects covered in the Report

Overview of the Benign Prostatic Hyperplasia (BPH) Drugs market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Table Of Content

Scope

Table of Content

1 Industrial Chain Overview

1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry

1.1.1 Overview

1.1.2 Characteristics of Benign Prostatic Hyperplasia (BPH) Drugs

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Alpha-blocker

1.3.2 Phosphodiesterase Type-5 Inhibitors

1.3.3 5-alpha-Reductase Inhibitors

1.4 End-Use List

1.4.1 Demand in Hospitals

1.4.2 Demand in Clinics

1.4.3 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 Astellas Pharma Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Eli Lilly Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 GlaxoSmithKline Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Sanofi Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 ADC Therapeutics Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Bayer HealthCare Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Bristol-Myers Squibb Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Valeant Pharmaceuticals Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Endo Pharmaceuticals Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Foresee Pharmaceuticals Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Madrigal Pharmaceuticals Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Merck Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Novartis Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Spectrum Pharmaceuticals Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Takeda Pharmaceuticals Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Teva Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Advaxis Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 ANI Pharmaceuticals Overview

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 BHR Pharma Overview

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in Alpha-blocker

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in Phosphodiesterase Type-5 Inhibitors

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in 5-alpha-Reductase Inhibitors

5.2.3.1 Market Size

5.2.3.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Hospitals

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Clinics

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Others

6.2.3.1 Market Size

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Benign Prostatic Hyperplasia (BPH) Drugs Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Volume Share by Manufacturers in 2019, in Volume

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in Alpha-blocker, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Alpha-blocker, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Phosphodiesterase Type-5 Inhibitors, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Phosphodiesterase Type-5 Inhibitors, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in 5-alpha-Reductase Inhibitors, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in 5-alpha-Reductase Inhibitors, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table Astellas Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ADC Therapeutics Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ADC Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bayer HealthCare Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Valeant Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Endo Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Foresee Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Madrigal Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merck Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novartis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Spectrum Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Takeda Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Teva Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Advaxis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ANI Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table BHR Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Volume

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Volume by Product Type Segment 2019-2025, in Volume

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Table Global Market Volume by End-Use Segment 2019-2025, in Volume

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

According to 99Strategy, the Global Benign Prostatic Hyperplasia (BPH) Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Benign Prostatic Hyperplasia (BPH) Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Astellas Pharma

Eli Lilly

GlaxoSmithKline

Sanofi

ADC Therapeutics

Bayer HealthCare

Bristol-Myers Squibb

Valeant Pharmaceuticals

Endo Pharmaceuticals

Foresee Pharmaceuticals

Madrigal Pharmaceuticals

Merck

Novartis

Spectrum Pharmaceuticals

Takeda Pharmaceuticals

Teva

Advaxis

ANI Pharmaceuticals

BHR Pharma

Key Product Type

Alpha-blocker

Phosphodiesterase Type-5 Inhibitors

5-alpha-Reductase Inhibitors

Market by Application

Hospitals

Clinics

Others

Main Aspects covered in the Report

Overview of the Benign Prostatic Hyperplasia (BPH) Drugs market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Scope

Table of Content

1 Industrial Chain Overview

1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry

1.1.1 Overview

1.1.2 Characteristics of Benign Prostatic Hyperplasia (BPH) Drugs

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Alpha-blocker

1.3.2 Phosphodiesterase Type-5 Inhibitors

1.3.3 5-alpha-Reductase Inhibitors

1.4 End-Use List

1.4.1 Demand in Hospitals

1.4.2 Demand in Clinics

1.4.3 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 Astellas Pharma Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Eli Lilly Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 GlaxoSmithKline Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Sanofi Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 ADC Therapeutics Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Bayer HealthCare Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Bristol-Myers Squibb Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Valeant Pharmaceuticals Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Endo Pharmaceuticals Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Foresee Pharmaceuticals Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Madrigal Pharmaceuticals Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Merck Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Novartis Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Spectrum Pharmaceuticals Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Takeda Pharmaceuticals Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Teva Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Advaxis Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 ANI Pharmaceuticals Overview

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 BHR Pharma Overview

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in Alpha-blocker

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in Phosphodiesterase Type-5 Inhibitors

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in 5-alpha-Reductase Inhibitors

5.2.3.1 Market Size

5.2.3.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Hospitals

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Clinics

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Others

6.2.3.1 Market Size

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Benign Prostatic Hyperplasia (BPH) Drugs Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Volume Share by Manufacturers in 2019, in Volume

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in Alpha-blocker, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Alpha-blocker, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Phosphodiesterase Type-5 Inhibitors, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Phosphodiesterase Type-5 Inhibitors, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in 5-alpha-Reductase Inhibitors, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in 5-alpha-Reductase Inhibitors, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Hospitals, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Clinics, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table Astellas Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ADC Therapeutics Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ADC Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bayer HealthCare Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Valeant Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Endo Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Foresee Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Madrigal Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merck Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novartis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Spectrum Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Takeda Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Teva Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Advaxis Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ANI Pharmaceuticals Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table BHR Pharma Overview List

Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Volume

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Volume by Product Type Segment 2019-2025, in Volume

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Table Global Market Volume by End-Use Segment 2019-2025, in Volume

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS